AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Drvilda Met 500mg/50mg Tablet IR

Prescription Icon
Prescription Required

Marketer

DR Best pharmaceuticals Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Drvilda Met 500mg/50mg Tablet IR

DiabetaComb 500mg/50mg Immediate-Release tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications like nephropathy and retinopathy, potentially lowering the risk of cardiovascular events. DiabetaComb 500mg/50mg IR may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a prescribed diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Effective blood sugar regulation prevents future complications. Continued adherence to the doctor's dietary and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts disease control. Common adverse events include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; patients must understand its recognition and management. This medication isn't suitable for all individuals. Prior to initiating therapy, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should consult their doctor. Potential drug interactions necessitate disclosure of all medications to ensure patient safety. Alcohol should be minimized due to its hypoglycemic effects. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Drvilda Met 500mg/50mg Tablet IR

No information provided. A rephrased text cannot be generated.

Uses of Drvilda Met 500mg/50mg Tablet IR

Managing Type 2 Diabetes

Major Benefits of Drvilda Met 500mg/50mg Tablet IR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg/50mg Drvilda Met Tablet IR whole; do not chew, crush, or divide it. Consume this medication with a meal.

Common Side effects of Drvilda Met 500mg/50mg Tablet IR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Drvilda Met 500mg/50mg Tablet IR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg/50mg Drvilda Met Tablet IR whole; avoid chewing, crushing, or breaking it. Consume this medication with food.

How Drvilda Met 500mg/50mg Tablet IR works:

Metformin and glimepiride 500mg/50mg immediate-release tablets (Drvilda) offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Drvilda Met 500mg/50mg Immediate-Release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Drvilda Met 500mg/50mg Immediate-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Drvilda Met 500mg/50mg Immediate-Release tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with kidney impairment, the use of Drvilda Met 500mg/50mg Immediate-Release tablets requires careful consideration. Dosage modification of Drvilda Met 500mg/50mg IR tablets may be necessary. A physician's consultation is recommended.

LiverLiverUNSAFE

The use of Drvilda Met 500mg/50mg Immediate-Release tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Drvilda Met 500mg/50mg Tablet IR :

Should you forget a Drvilda Met 500mg/50mg Immediate-Release tablet, take it immediately upon remembering. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Drvilda Met 500mg/50mg Tablet IR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Drvilda Met 500mg/50mg Tablet IR

Drvilda Met 500mg/50mg Tablet IR typically doesn't cause hypoglycemia by itself. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness may indicate hypoglycemia. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Drvilda Met 500mg/50mg Tablet IR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Drvilda Met 500mg/50mg Tablet IR is contraindicated in patients allergic to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Drvilda Met 500mg/50mg Tablet IR combines metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Drvilda Met 500mg/50mg Tablet IR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Drvilda Met 500mg/50mg Tablet IR and seek immediate medical attention.
Prolonged use of Drvilda Met 500mg/50mg Tablet IR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Drvilda Met 500mg/50mg Tablet IR is safe when used as directed by your doctor. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if you also take insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Drvilda Met 500mg/50mg Ta...
69
MRP 80
13% off